Sign in

You're signed outSign in or to get full access.

K. Charles Janac

K. Charles Janac

Chief Executive Officer at Arteris
CEO
Executive
Board

About K. Charles Janac

K. Charles Janac, age 67, is Chairman, President and Chief Executive Officer of Arteris, Inc. (ticker: AIP), serving as CEO since 2005 and Chairman since 2007, with 40 years of technology operating and EDA industry experience and an MBA from Stanford GSB (BS/MS in Chemistry from Tufts) . Under his leadership, Arteris reported 2024 revenue of $57.7M vs. $53.7M in 2023, reflecting continued growth since the 2021 IPO . He holds significant skin-in-the-game through a 24.3% beneficial stake as of April 10, 2025, aligning incentives with shareholders .

Past Roles

OrganizationRoleYearsStrategic impact
Arteris, Inc.Chairman; President & CEOChairman since 2007; CEO since 2005Scaled NoC IP leadership; guided IPO; sustained revenue growth
Nanomix, Inc.President & CEO2001–2003Built early-stage nanotechnology startup
Infinity CapitalEntrepreneur-in-Residence1999–2001Evaluated IT investments for VC firm
Smart MachinesFounder; President & CEO1993–1999Built semiconductor automation firm; sold to Brooks Automation in 1999
Cadence Design SystemsMarketing & Sales leadership1983–1992Helped scale into top-tier technical software firm

External Roles

OrganizationRoleYearsNotes
Transchip (affiliated company)DirectorSince Aug 2022Arteris retains minority non‑controlling interest; Janac serves on board

Fixed Compensation

Metric20232024
Base Salary ($)404,000 404,000
Target Bonus % of Salary92% 92%
Target Bonus ($)371,680 (computed) 371,680 (computed)
Bonus Achievement (% of Target)75% 94%
Actual Bonus Paid ($)278,760 349,379
RSU Grant (#)117,500 (Mar 2023 grant) 117,500 (Feb 2024 grant)
RSU Grant Fair Value ($)641,550 723,800
Other Compensation ($)13,200 (401k match) 6,060 (401k match)

Notes: 2024 base salary flat YoY; higher cash bonus payout on improved achievement; equity compensation via time-based RSUs (no options granted in 2024) .

Performance Compensation

  • Annual cash bonus framework: target set as % of salary (CEO 92%); payouts based on corporate financial/operational objectives and individual goals; 2024 payout at 94% of target; 2023 at 75% of target (specific metrics/weightings not disclosed) .
  • Equity awards: time-based RSUs vesting quarterly; no performance share units disclosed; no stock options granted to NEOs in 2024 (options are not a component of the program) .
Incentive TypeMetric(s)WeightingTargetActualPayout/Term
Annual Cash Bonus (2024)Corporate and individual goals (undisclosed)N/A92% of salary 94% of target Paid Feb 2025
RSUs (2024 grant)Time-based vestN/A117,500 RSUs N/A1/16 quarterly from Apr 1, 2024
RSUs (2023 grant)Time-based vestN/A117,500 RSUs N/A1/16 quarterly from Apr 1, 2023

Equity Ownership & Alignment

  • Beneficial ownership: Janac beneficially owns 10,072,859 shares (24.3%) including 9,907,691 shares held by Bayview Legacy, LLC (manager: Janac), 102,666 shares direct, 56,252 via trust, and 6,250 options exercisable within 60 days; shares outstanding 41,463,290 as of Apr 10, 2025 .
  • Pledging/hedging: Company policy prohibits hedging, pledging/margin of company stock—reducing misalignment risk .
  • Executive ownership guidelines: Proxy discloses non-employee director ownership guidelines adopted Feb 2025; no executive ownership guideline disclosed .
Ownership Snapshot (as of Apr 10, 2025)Shares% of Outstanding
Bayview Legacy, LLC (managed by Janac)9,907,691 23.9%
K. Charles Janac total beneficial10,072,859 (incl. above) 24.3%
Shares Outstanding (context)41,463,290
  • Vested vs. unvested equity (12/31/2024): Janac held unvested RSUs of 13,213 (2021 grant), 66,094 (2023 grant), 95,469 (2024 grant); RSU vesting schedules: 2021 award: 12.5% on May 1, 2022 then quarterly; 2023 and 2024 awards: 1/16 quarterly from Apr 1 of grant year . Options: 6,250 exercisable within 60 days as of Apr 10, 2025 .
Unvested Equity Detail (12/31/2024)Unvested SharesVesting ScheduleMarket Value Ref ($10.19)
RSUs (grant 11/11/2021)13,213 12.5% on May 1, 2022; then quarterly over remaining 14 quarters 134,640
RSUs (grant 3/7/2023)66,094 1/16 quarterly from Apr 1, 2023 673,498
RSUs (grant 2/1/2024)95,469 1/16 quarterly from Apr 1, 2024 972,829
  • Forward vesting cadence (supply overhang): 2023 grant has 9 quarterly vest tranches remaining (~7,344 shares/quarter), and 2024 grant has 13 quarterly tranches remaining (~7,344 shares/quarter), subject to continued service—potentially ~16 quarterly RSU settlements totaling ~202k shares through 2028 (derived from grant sizes and schedules) .

Employment Terms

  • Severance: If terminated without cause or resigns for good reason outside a change in control (CIC) window: 12 months salary and 12 months healthcare for CEO (lesser benefits for other NEOs) .
  • CIC economics (double trigger within −3 months to +12 months of CIC): 18 months salary for CEO; pro‑rated target bonus; 18 months healthcare; full accelerated vesting of time‑based equity (performance awards governed by award terms) .
  • Agreement term: severance/CIC agreements renewed July 2024 for a three‑year term .
  • Clawback: Policy effective Oct 2, 2023 aligned with SEC/Nasdaq rules covers incentive comp tied to financial reporting measures .
  • Insider trading policy: preclearance for certain insiders; blackout windows; hedging/pledging prohibited .

Board Governance

  • Board service: Director since 2005; Chairman since 2007; dual role as CEO + Chairman .
  • Committee roles: Janac is not listed as a member of Audit, Compensation, or Nominating & Corporate Governance Committees; those committees are fully independent .
  • Independence and structure: Six of seven directors are independent under Nasdaq rules (i.e., all except the CEO/Chairman); Board employs a Lead Independent Director (Wayne C. Cantwell) to preside over executive sessions and act as liaison .
  • Attendance: Board met 7 times in 2024; all directors attended at least 75% of their meetings; Audit (4), Compensation (5), Nominating (4) meetings in 2024 .

Director Compensation (context for dual role)

  • Employees receive no additional pay for director service; non‑employee directors are paid retainers and RSUs; all director equity fully vests upon change in control .
  • Stock ownership guidelines apply to non‑employee directors (5x cash retainer; 5‑year compliance window; measured at acquisition cost) from Feb 2025—not to executives .

Performance & Track Record

YearRevenue ($M)
202353.7
202457.7

Additional operating highlights referenced by management include >3B SoCs shipped by customers incorporating Arteris IP, and growth in SoC integration automation products (CEO letters) .

Compensation Structure Analysis

  • Cash vs. equity mix: Base salary flat YoY; RSU grant value increased in 2024 ($723.8k vs. $641.6k), keeping a high portion of at‑risk, equity-based pay .
  • Options to RSUs shift: No stock options granted to NEOs in 2024; the program relies on time‑based RSUs, lowering incentive risk vs. performance‑based equity but aligning with retention .
  • Bonus rigor: Payout improved to 94% of target in 2024 (from 75% in 2023), with metrics undisclosed; absence of disclosed goal calibration limits external assessment of rigor .
  • Clawback/controls: SEC‑compliant clawback and strict insider trading/hedging/pledging prohibitions support alignment and risk management .

Related Party and Other Governance Items

  • Bayview Legacy, LLC: Largest holder (23.9%); Janac is manager and shares dispositive power—aligns incentives but concentrates control .
  • Section 16 compliance: Company noted a Form 4 correction on Jan 8, 2025 for Janac correcting inadvertent overstatements; otherwise in compliance for 2024 .

Risk Indicators & Red Flags

  • Governance: Combined CEO/Chair structure—mitigated by Lead Independent Director and a majority‑independent board and committees .
  • Concentrated ownership: Janac’s ~24% stake and Bayview’s holdings concentrate voting power—can be positive for alignment but raises entrenchment considerations .
  • Disclosure gaps: No detailed disclosure of bonus metric targets/weightings or executive stock ownership guidelines, limiting external pay‑for‑performance evaluation .

Compensation Peer Group and Say‑on‑Pay

  • Peer group/target percentile: Not disclosed in EGC‑scaled proxy .
  • Say‑on‑Pay: Not required as an Emerging Growth Company; no advisory vote held .

Expertise & Qualifications

  • Education: BS/MS (Organic Chemistry) Tufts; MBA Stanford GSB .
  • Domain expertise: EDA/IP business building (Cadence; Arteris), semiconductor automation (Smart Machines), venture and startup leadership (Nanomix; Infinity Capital) .
  • Board experience: Director of Transchip; long‑tenured Arteris board leadership .

Investment Implications

  • Alignment: Very high insider alignment via 24.3% beneficial stake and no pledging/hedging permitted—reducing agency risk; however, concentrated control can diminish minority shareholder influence .
  • Supply overhang: Predictable RSU settlement cadence (~7.3k shares per quarter for each of 2023 and 2024 grants; ~16 tranches remaining combined) may create modest, periodic insider selling pressure upon vesting and tax withholding .
  • Retention/continuity: Renewed 3‑year severance/CIC agreements with double‑trigger vesting accelerate equity only upon qualifying separation around a CIC, balancing retention with change‑of‑control alignment .
  • Performance linkage: Cash bonus improved in 2024 (94% of target), but lack of disclosed scorecards limits external assessment of pay‑for‑performance tightness; equity is time‑based, emphasizing retention over explicit performance stretch .
  • Governance checks: Lead Independent Director and fully independent key committees mitigate combined Chair/CEO risk; EGC status means no Say‑on‑Pay yet, modestly reducing direct shareholder feedback loops on compensation .